6.
Gomez-Acebo I, Dierssen-Sotos T, de Pedro M, Perez-Gomez B, Castano-Vinyals G, Fernandez-Villa T
. Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study. BMC Public Health. 2018; 18(1):1134.
PMC: 6150967.
DOI: 10.1186/s12889-018-6019-z.
View
7.
Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E
. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778.
DOI: 10.1016/S0140-6736(17)32448-0.
View
8.
Ilhan M, Yapar D
. Alcohol consumption and alcohol policy. Turk J Med Sci. 2020; 50(5):1197-1202.
PMC: 7491269.
DOI: 10.3906/sag-2002-237.
View
9.
. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998; 28(3):551-8.
DOI: 10.1017/s0033291798006667.
View
10.
Pullen R, Kent K, Sharman M, Schumacher T, Brown L
. A Comparison of Diet Quality in a Sample of Rural and Urban Australian Adults. Nutrients. 2021; 13(11).
PMC: 8624345.
DOI: 10.3390/nu13114130.
View
11.
Umar N, King D, Chandan J, Bhala N, Nirantharakumar K, Adderley N
. The association between inflammatory bowel disease and mental ill health: a retrospective cohort study using data from UK primary care. Aliment Pharmacol Ther. 2022; 56(5):814-822.
DOI: 10.1111/apt.17110.
View
12.
Raman M, Rajagopalan V, Kaur S, Reimer R, Ma C, Ghosh S
. Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review. Inflamm Bowel Dis. 2021; 28(7):1100-1111.
DOI: 10.1093/ibd/izab218.
View
13.
Zhuang X, Li T, Li M, Huang S, Qiu Y, Feng R
. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019; 25(11):1751-1763.
DOI: 10.1093/ibd/izz188.
View
14.
Beurel E, Toups M, Nemeroff C
. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020; 107(2):234-256.
PMC: 7381373.
DOI: 10.1016/j.neuron.2020.06.002.
View
15.
Ananthakrishnan A, Nguyen D, Sauk J, Yajnik V, Xavier R
. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm Bowel Dis. 2014; 20(5):783-9.
PMC: 4113010.
DOI: 10.1097/MIB.0000000000000014.
View
16.
Yu R, Liu C, Zhang J, Li J, Tian S, Ding F
. Correlation Analysis Between Disease Activity and Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Inflammatory Bowel Disease. Nat Sci Sleep. 2023; 15:407-421.
PMC: 10228587.
DOI: 10.2147/NSS.S407388.
View
17.
Bisgaard T, Poulsen G, Allin K, Keefer L, Ananthakrishnan A, Jess T
. Longitudinal trajectories of anxiety, depression, and bipolar disorder in inflammatory bowel disease: a population-based cohort study. EClinicalMedicine. 2023; 59:101986.
PMC: 10184046.
DOI: 10.1016/j.eclinm.2023.101986.
View
18.
Sekiya T, Hidano S, Takaki S
. Tonic TCR and IL-1β signaling mediate phenotypic alterations of naive CD4 T cells. Cell Rep. 2024; 43(3):113954.
DOI: 10.1016/j.celrep.2024.113954.
View
19.
Ananthakrishnan A, Higuchi L, Huang E, Khalili H, Richter J, Fuchs C
. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012; 156(5):350-9.
PMC: 3369539.
DOI: 10.7326/0003-4819-156-5-201203060-00007.
View
20.
Monton C, Perez Echeverria M, Campos R, Garcia Campayo J, Lobo A
. [Anxiety scales and Goldberg's depression: an efficient interview guide for the detection of psychologic distress]. Aten Primaria. 1993; 12(6):345-9.
View